Alyeska Investment Group
BLTE

Alyeska Investment Group’s Belite Bio BLTE Stock Holding History

Alyeska Investment Group’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-83,623
Closed -$5.54M – 570
2025
Q1 		$5.54M Buy
+83,623
New +$5.04M 0.02% 359

Other funds holding BLTE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Alyeska Investment Group's BLTE Position: Q2 2025 in Review

Alyeska Investment Group sold out of Belite Bio (BLTE) in Q2 2025, closing a stake of 83,623 shares — an estimated $5.54M sold.

Alyeska Investment Group first reported a position in BLTE in Q1 2025 and held it in 1 quarter. The position peaked at $5.54M in Q1 2025. 18 funds tracked by Wall St. Rank hold BLTE as of Q2 2025.

  • Alyeska Investment Group reported no remaining Belite Bio position as of Q2 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 83,623 Belite Bio shares in Q2 2025, an estimated $5.54M.
  • Alyeska Investment Group first reported a position in Belite Bio in Q1 2025 and held it in 1 quarter.
  • Alyeska Investment Group's Belite Bio position peaked at $5.54M in Q1 2025.
  • 18 funds tracked by Wall St. Rank held Belite Bio as of Q2 2025.

Based on Alyeska Investment Group's 13F filing for Q2 2025, filed 14 Aug 2025.